PUBLISHER: The Business Research Company | PRODUCT CODE: 1939193
PUBLISHER: The Business Research Company | PRODUCT CODE: 1939193
Adaptive radiotherapy software is a specialized tool in radiation oncology that allows real-time or near-real-time adjustments to radiotherapy treatment plans based on changes in a patient's anatomy, tumor size, or position during treatment. It combines imaging data, including CT, MRI, or cone-beam CT, with treatment planning systems to optimize radiation delivery, enhance tumor targeting, and reduce exposure to surrounding healthy tissues.
The primary component types of adaptive radiotherapy software are software and services. Software includes adaptive radiotherapy programs and platforms used for planning, monitoring, and delivering precise radiation treatments. These solutions are deployed through on-premises and cloud-based platforms. Applications include prostate cancer, head and neck cancer, breast cancer, lung cancer, and other conditions. End-users include hospitals, cancer treatment centers, research institutes, and related healthcare facilities.
Tariffs have influenced the adaptive radiotherapy software market by increasing costs for imported software components, imaging integration tools, and IT infrastructure used in advanced radiotherapy systems. Higher tariffs have particularly impacted hospitals and cancer treatment centers in developing regions that rely on imported oncology software solutions, especially across Asia-Pacific and Latin America. These cost pressures have slowed software upgrades and new installations in price-sensitive markets. However, tariffs have also encouraged regional software development, local partnerships, and cloud-based deployment models, supporting long-term market resilience and innovation.
The adaptive radiotherapy software market research report is one of a series of new reports from The Business Research Company that provides adaptive radiotherapy software market statistics, including adaptive radiotherapy software industry global market size, regional shares, competitors with a adaptive radiotherapy software market share, detailed adaptive radiotherapy software market segments, market trends and opportunities, and any further data you may need to thrive in the adaptive radiotherapy software industry. This adaptive radiotherapy software market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The adaptive radiotherapy software market size has grown rapidly in recent years. It will grow from $0.7 billion in 2025 to $0.81 billion in 2026 at a compound annual growth rate (CAGR) of 14.3%. The growth in the historic period can be attributed to increasing adoption of image-guided radiotherapy, rising cancer incidence globally, advancements in radiation oncology software, demand for improved treatment accuracy, expansion of radiotherapy centers.
The adaptive radiotherapy software market size is expected to see rapid growth in the next few years. It will grow to $1.36 billion in 2030 at a compound annual growth rate (CAGR) of 14.0%. The growth in the forecast period can be attributed to growing demand for personalized cancer treatment, integration of AI-driven treatment adaptation, rising adoption of cloud-based oncology software, increasing focus on reducing radiation toxicity, investments in advanced oncology infrastructure. Major trends in the forecast period include adaptive treatment planning, image-guided dose optimization, personalized radiation therapy protocols, workflow automation in radiation oncology, multi-modality imaging integration.
The increasing prevalence of cancer is expected to drive the expansion of the adaptive radiotherapy software market in the coming years. Cancer cases indicate the number of individuals diagnosed with cancer within a specific population over a defined timeframe. The incidence of cancer is growing among aging populations, as longer lifespans lead to a greater accumulation of genetic mutations, which raises the likelihood of developing the disease. Adaptive radiotherapy software aids cancer treatment by modifying radiation therapy in real time according to changes in tumor size, shape, and patient anatomy, enhancing precision, optimizing tumor targeting, and reducing harm to healthy tissues. For example, in February 2025, Cancer Australia, an Australian government agency, reported 4,641 new cases of pancreatic cancer in 2024, including 2,414 males and 2,227 females. Thus, the rising prevalence of cancer is fueling the growth of the adaptive radiotherapy software market.
Leading companies in the adaptive radiotherapy software market are focusing on technological innovations such as artificial intelligence-powered adaptive CT-Linac systems to improve real-time tumor targeting, treatment precision, and patient outcomes. An artificial intelligence-powered adaptive CT-Linac is a radiation therapy system that combines computed tomography imaging with a linear accelerator, utilizing artificial intelligence to adapt radiation delivery during treatment based on the tumor's evolving characteristics. For example, in May 2024, Elekta AB, a pharmaceutical and medical technology company based in Sweden, introduced Evo, a system designed to provide highly accurate and efficient radiotherapy. Evo delivers personalized cancer radiation treatment by offering advanced imaging capabilities enhanced by artificial intelligence, allowing clinicians to clearly visualize tumors and make treatment adjustments either during or between sessions. This technology aims to improve accuracy, reduce adverse effects, and enhance patient quality of life, while offering clinics the flexibility to implement these advancements at a pace that suits their operations.
In April 2024, GE Healthcare Technologies Inc., a medical diagnostics company based in the United States, acquired MIM Software Inc. for an undisclosed amount. This acquisition is intended to support GE Healthcare's precision care strategy by incorporating MIM Software's artificial intelligence-powered imaging analysis and digital workflow tools, thereby improving the delivery of precise, coordinated, and efficient care across various disease areas. MIM Software Inc. is a United States-based software company that specializes in adaptive radiotherapy solutions.
Major companies operating in the adaptive radiotherapy software market are Siemens Healthineers AG, Koninklijke Philips N.V., GE HealthCare Technologies Inc., Elekta AB, Shanghai United Imaging Healthcare Co. Ltd., United Imaging Healthcare Co. Ltd., Brainlab AG, Accuray Incorporated, RaySearch Laboratories AB, ViewRay Inc., C-RAD AB, Standard Imaging Inc., LAP GmbH Laser Applikationen, Oncology Systems Limited, DOSIsoft SA, Mirada Medical Ltd., Limbus AI, MagnetTx Oncology Solutions Ltd., Spectronic Medical AB, Akesis Inc.
North America was the largest region in the adaptive radiotherapy software market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the adaptive radiotherapy software market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the adaptive radiotherapy software market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The adaptive radiotherapy software market consists of revenues earned by entities by providing services such as imaging data processing services, radiation dose adjustment services, real-time monitoring services, clinical workflow customization services, and regulatory compliance services. The market value includes the value of related goods sold by the service provider or included within the service offering. The adaptive radiotherapy software market also includes sales of imaging systems, treatment planning systems, verification tools, deformable registration tools, oncology information systems, and dose tracking systems. Values in this market are 'factory gate' values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Adaptive Radiotherapy Software Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses adaptive radiotherapy software market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for adaptive radiotherapy software ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The adaptive radiotherapy software market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.